Why Does CAR-T Cell Therapy Require a Hospital Stay?

While some specialized centers offer outpatient monitoring for selected patients, many CAR-T cell therapy protocols require an inpatient hospital stay after the infusion. This observation period is necessary because the treatment can trigger intense immune reactions that require rapid, specialized medical intervention ^[1].

When the newly engineered immune cells are infused, they recognize and attack cancer cells carrying their specific target. As they do, they release inflammatory signals that can cause side effects known as Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) ^[1]. Because these reactions can escalate quickly, close monitoring ensures your care team can administer medications to control the inflammation at the first sign of trouble ^[2]. While most patients do not develop the most severe forms of these reactions, the intensive observation is a necessary precaution.

The CAR-T Timeline: What to Expect

The exact schedule depends on your specific CAR-T product, your health, and your treatment center’s protocols ^[3]. Generally, the process involves:

• Lymphodepleting Chemotherapy: A few days of mild chemotherapy to prepare your body to accept the new CAR-T cells ^[4].
• Infusion Day (Day 0): The CAR-T cells are administered through an IV.
• Observation Period: Depending on the center and product, you will be monitored closely in the hospital or in an intensive outpatient program for the first 1 to 2 weeks ^[3][5].
• Post-Discharge Proximity: After the initial observation, you must stay near the treatment center (usually within a specific driving time) with a 24/7 caregiver for the first several weeks ^[5].

Understanding the Risks: CRS and ICANS

Cytokine Release Syndrome (CRS) is a common inflammatory response that happens when your new CAR-T cells multiply and become active ^[6]. It typically starts within the first week, with onset ranging from day 1 to day 17 depending on the product and patient ^[6]. Symptoms often start like a severe flu—with high fevers, chills, and muscle aches—but can quickly escalate to dangerous drops in blood pressure and low oxygen levels ^[7].

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) is a neurologic side effect that often starts within the first week after infusion, though it can occur later ^[8]. Early signs can be subtle, such as confusion, difficulty finding words (aphasia), attention changes, or tremors ^[9]. Without rapid intervention, ICANS can progress to more serious complications like seizures or swelling in the brain (cerebral edema) ^[9].

The Need for Specialized Monitoring

Whether inpatient or through a rigorous outpatient program, your medical team will conduct intensive monitoring:

• Frequent Vital Sign Checks: Your team will frequently check your temperature, blood pressure, heart rate, and oxygen levels to catch the earliest signs of CRS ^[10].
• Serial Neurologic Exams: Nurses and doctors will perform regular cognitive tests—such as asking you to answer specific questions, follow commands, or write a sentence—to detect the first hints of ICANS ^[11].
• Blood and Organ Monitoring: Both the lymphodepleting chemotherapy and the CAR-T cells themselves can cause prolonged low blood cell counts (cytopenias) and weaken your immune system ^[11]. Your team will run blood tests as often as needed to monitor for infection risk, kidney changes, and other organ functions ^[12].

Treatments to Control CRS and ICANS

If your immune system overreacts, doctors use specific medications to control the inflammation while balancing the need to preserve the cancer-fighting effect of the CAR-T cells.

• Tocilizumab: An intravenous drug used for clinically significant CRS. It works by blocking a specific inflammatory pathway (IL-6) causing the reaction ^[13][2].
• Corticosteroids: Drugs like dexamethasone are the primary treatment for moderate-to-severe ICANS. They are also used for severe CRS if tocilizumab is not enough to control the symptoms ^[13][2].

In severe cases, you may be temporarily moved to the intensive care unit (ICU) for extra breathing or blood pressure support ^[10][14].

Urgent Symptoms After Discharge

Because CRS, ICANS, and infections can occur or return after you leave the hospital, you will need a 24/7 adult caregiver and will be restricted from driving or operating machinery for a period specified by your team. Call your CAR-T center immediately or seek emergency care if you experience:

• Fever or chills: Ask your center for their exact temperature threshold, often 100.4°F (38°C). Note: Never assume a fever is just CRS; it could be a dangerous infection ^[11].
• Difficulty breathing, dizziness, or faintness.
• New confusion, trouble speaking or writing, or severe drowsiness.
• Tremors or a seizure ^[9].